Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children

Pediatr Infect Dis J. 2021 Dec 1;40(12):e491-e492. doi: 10.1097/INF.0000000000003280.

Abstract

Multisystem inflammatory syndrome in children is a rare, potentially life-threatening postinfectious complication in children after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. It is currently unknown if multisystem inflammatory syndrome in children (MIS-C) can recur upon reinfection with SARS-CoV-2. Here, we report on a former MIS-C patient who was reinfected with SARS-CoV-2 without recurrence of MIS-C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Biomarkers
  • COVID-19 / complications*
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Inflammation / blood
  • Inflammation / metabolism
  • Methylprednisolone / therapeutic use
  • Prednisone / therapeutic use
  • Recurrence
  • Reinfection
  • SARS-CoV-2*
  • Systemic Inflammatory Response Syndrome / complications*

Substances

  • Biomarkers
  • Immunoglobulins, Intravenous
  • Prednisone
  • Methylprednisolone

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related